NEW YORK ( TheStreet) -- With an 11% jump in new-home sales in June, Jim Cramer's eyes are on Centex ( CTX), he said on Monday's "Stop Trading!" segment on CNBC.

Pulte's ( PHM) deal to buy Centex will close in August, which will be "monumental." He said the "whole group's been on a tear," but with the catalyst of the closing of the Pulte deal, Centex is where he'd put his money.

Cramer called Capital One ( COF) "a battleground" and advised viewers that, after its "big leap back to $30," it would likely pull back "before it has its next one."

Cramer said that recent acquisitions -- including Bristol-Myers' ( BMY), Johnson & Johnson's ( JNJ) and First Niagara's ( FNFG) -- "are very good." "I think that people should start recognizing that when your stock goes up after a deal, when people see this, it bring more and more mergers," he said.

Cramer said that had Eaton ( ETN) reported today, "I think it would've barely gone up." He said the stock is now "very overbought" and recommended waiting for a pullback to buy. "Eaton has been one of my favorites for a long time," he said, but "not up here. I don't want to buy it in the $50s."

--Rebecca Corvino writes from New York.

If you liked this article you might like

Dow Drops Over 250 Points to End Six-Session Winning Streak

Dow Drops Over 250 Points to End Six-Session Winning Streak

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over